1. Patients with presence, coagulopathy or hypotension, 2. Pregnant and lactating women, 3. People with allergies or allergies to Xuebijing Injection and its components, 4. Severe basic diseases that affect survival, including: uncontrolled malignant tumors that have metastasized and cannot be removed, blood diseases, cachexia, active bleeding, severe malnutrition, HIV, etc., 5. Pulmonary tumors caused by obstructive pneumonia, severe interstitial fibrosis, alveolar proteinosis, allergic alveolitis, 6. Continued use of immunosuppressive agents or organ transplants in the last 6 months, 7. Extracorporeal life support (ECMO, ECCO2R, RRT), 8. Expected deaths within 48 hours, 9. Clinicians judge inappropriate.

1. Patients with presence, coagulopathy or hypotension, 2. Pregnant and lactating women, 3. People with allergies or allergies to Xuebijing Injection and its components, 4. Severe basic diseases that affect survival, including: uncontrolled malignant tumors that have metastasized and cannot be removed, blood diseases, cachexia, active bleeding, severe malnutrition, HIV, etc., 5. Pulmonary tumors caused by obstructive pneumonia, severe interstitial fibrosis, alveolar proteinosis, allergic alveolitis, 6. Continued use of immunosuppressive agents or organ transplants in the last 6 months, 7. Extracorporeal life support (ECMO, ECCO2R, RRT), 8. Expected deaths within 48 hours, 9. Clinicians judge inappropriate.